Financials
- Market Capitalization 79.5 M
- Employee 128
- Founded 1983
- CEO N/A
- Website www.herontx.com
- Headquarter Delaware, United States
- FIGI BBG000G2GJT7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4081 | ACET Adicet Bio, Inc. - Common Stock | 8.66 USD | -1.93% | -4.31% | +6.52% | +1024.68% | 80.96 M USD | ||
| 4087 | ENTX Entera Bio Ltd. - Ordinary Shares | 1.63 USD | +0.62% | -4.12% | +34.71% | -18.09% | 80.24 M USD | ||
| 4102 | CSBR Champions Oncology, Inc. - Common Stock | 5.67 USD | +0.18% | -5.81% | -10.57% | -27.40% | 78.74 M USD | ||
| 4109 | RNTX Rein Therapeutics, Inc. - Common Stock | 0.91 USD | -1.09% | -8.08% | -9.00% | -17.30% | 77.84 M USD |
Frequently asked questions about Heron Therapeutics, Inc. - Common Stock
What is the Heron Therapeutics, Inc. - Common Stock stock price today?
The current price of Heron Therapeutics, Inc. - Common Stock (HRTX) is 0.42. Over the past 24 hours, the stock has changed by -2.33%. Follow the HRTX chart for real-time price dynamics.
What is the stock ticker of Heron Therapeutics, Inc. - Common Stock?
Heron Therapeutics, Inc. - Common Stock trades under the ticker HRTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Heron Therapeutics, Inc. - Common Stock stock going up?
HRTX has changed by 0.00% over the last week, +2.44% over the last month, and -79.61% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Heron Therapeutics, Inc. - Common Stock net income for the last quarter?
Heron Therapeutics, Inc. - Common Stock reported net income of -8.11 M for the last quarter. The previous quarter showed -2.95 M, which means net income changed by -174.58%.
How many employees does Heron Therapeutics, Inc. - Common Stock have?
As of the latest available data, Heron Therapeutics, Inc. - Common Stock has 128 employees. Workforce size can provide additional context about the company's scale and operations.
What is Heron Therapeutics, Inc. - Common Stock EBITDA?
Heron Therapeutics, Inc. - Common Stock EBITDA is 6.4 M, and its EBITDA margin is 18.44%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Heron Therapeutics, Inc. - Common Stock stock?
You can buy Heron Therapeutics, Inc. - Common Stock (HRTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Heron Therapeutics, Inc. - Common Stock stock?
Investing in Heron Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HRTX chart and related analysis on metatrader.com as part of your research.